Nilabh Shastri

Author PubWeight™ 52.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 2002 3.72
2 In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides. Nat Immunol 2006 2.62
3 Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum. Nat Immunol 2008 2.45
4 Leucine-tRNA initiates at CUG start codons for protein synthesis and presentation by MHC class I. Science 2012 2.30
5 The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules. Nat Immunol 2005 2.24
6 Hsp90alpha chaperones large C-terminally extended proteolytic intermediates in the MHC class I antigen processing pathway. Immunity 2006 2.18
7 A macromolecular delivery vehicle for protein-based vaccines: acid-degradable protein-loaded microgels. Proc Natl Acad Sci U S A 2003 2.14
8 Constitutive display of cryptic translation products by MHC class I molecules. Science 2003 1.67
9 Class I major histocompatibility complex presentation of antigens that escape from the parasitophorous vacuole of Toxoplasma gondii. Infect Immun 2005 1.66
10 Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells. J Immunol 2010 1.46
11 Enhanced antigen presentation and CTL activity by transduction of mature rather than immature dendritic cells with octaarginine-modified liposomes. J Control Release 2009 1.44
12 ERAAP synergizes with MHC class I molecules to make the final cut in the antigenic peptide precursors in the endoplasmic reticulum. Immunity 2006 1.43
13 Unanticipated antigens: translation initiation at CUG with leucine. PLoS Biol 2004 1.29
14 Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria. EMBO Mol Med 2013 1.28
15 A distinct translation initiation mechanism generates cryptic peptides for immune surveillance. PLoS One 2008 1.26
16 The final touches make perfect the peptide-MHC class I repertoire. Immunity 2007 1.23
17 SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade. Proc Natl Acad Sci U S A 2008 1.22
18 In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles. Proc Natl Acad Sci U S A 2005 1.22
19 The group II chaperonin TRiC protects proteolytic intermediates from degradation in the MHC class I antigen processing pathway. Mol Cell 2003 1.21
20 Coping with loss of perfection in the MHC class I peptide repertoire. Curr Opin Immunol 2008 1.21
21 Nonclassical MHC class Ib-restricted cytotoxic T cells monitor antigen processing in the endoplasmic reticulum. Nat Immunol 2012 1.14
22 Acid-degradable particles for protein-based vaccines: enhanced survival rate for tumor-challenged mice using ovalbumin model. Bioconjug Chem 2004 1.08
23 A ligand for the murine NK activation receptor Ly-49D: activation of tolerized NK cells from beta 2-microglobulin-deficient mice. J Immunol 2002 1.04
24 The synthesis of truncated polypeptides for immune surveillance and viral evasion. PLoS One 2010 1.04
25 Non-conventional sources of peptides presented by MHC class I. Cell Mol Life Sci 2011 1.03
26 The Toxoplasma gondii peptide AS15 elicits CD4 T cells that can control parasite burden. Infect Immun 2012 1.01
27 Critical role of endoplasmic reticulum aminopeptidase 1 in determining the length and sequence of peptides bound and presented by HLA-B27. Arthritis Rheumatol 2014 1.00
28 Location of the CD8 T cell epitope within the antigenic precursor determines immunogenicity and protection against the Toxoplasma gondii parasite. PLoS Pathog 2013 0.98
29 Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes. Mol Ther 2008 0.93
30 ERAAP and tapasin independently edit the amino and carboxyl termini of MHC class I peptides. J Immunol 2013 0.90
31 Endoplasmic reticulum aminopeptidase associated with antigen processing regulates quality of processed peptides presented by MHC class I molecules. J Immunol 2008 0.90
32 Topological journey of parasite-derived antigens for presentation by MHC class I molecules. Trends Immunol 2010 0.89
33 How H13 histocompatibility peptides differing by a single methyl group and lacking conventional MHC binding anchor motifs determine self-nonself discrimination. J Immunol 2002 0.89
34 Second class minors: molecular identification of the autosomal H46 histocompatibility locus as a peptide presented by major histocompatibility complex class II molecules. J Exp Med 2003 0.87
35 Immune surveillance for ERAAP dysfunction. Mol Immunol 2013 0.85
36 Cross-presentation of peptides from intracellular pathogens by MHC class I molecules. Ann N Y Acad Sci 2010 0.83
37 Mousepox detected in a research facility: case report and failure of mouse antibody production testing to identify Ectromelia virus in contaminated mouse serum. Comp Med 2009 0.81
38 Biochemical analysis of naturally processed antigenic peptides presented by MHC class I molecules. Methods Mol Biol 2013 0.77
39 Construction and destruction of MHC class I in the peptide-loading complex. Nat Immunol 2007 0.75
40 Immune surveillance obstructed by viral mRNA. Proc Natl Acad Sci U S A 2008 0.75